| Dr Charles William Breckenridge, MD | |
|
5917 Crosstown Expressway Sh 286, Corpus Christi, TX 78417 | |
| (361) 854-0811 | |
| (361) 806-5040 |
| Full Name | Dr Charles William Breckenridge |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 35 Years |
| Location | 5917 Crosstown Expressway Sh 286, Corpus Christi, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366454662 | NPI | - | NPPES |
| 1106783-02 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | J8212 (Texas) | Secondary |
| 207X00000X | Orthopaedic Surgery | J8212 (Texas) | Primary |
| Entity Name | Orthopedic Associates Of Corpus Christi |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235170283 PECOS PAC ID: 3274520242 Enrollment ID: O20040429001564 |
News Archive
​Researchers from The University of Manchester and Central Manchester University Hospitals NHS Trust have identified proteins in the blood that could be used to predict whether a woman in her first pregnancy is at increased risk of developing pre-eclampsia.
In 2004, researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center announced a crucial discovery in the understanding of cellular aging. They found that as cells and tissues age, the expression of a key protein, called p16INK4a, dramatically increases in most mammalian organs. Because p16INK4a is a tumor suppressor protein, cancer researchers are interested in its role in cellular aging and cancer prevention.
Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute and Northern Arizona University, and now protected by a patent issued today by the U.S. Patent and Trademark Office.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles William Breckenridge, MD 5917 Crosstown Expressway Sh 286, Corpus Christi, TX 78417 Ph: (361) 854-0811 | Dr Charles William Breckenridge, MD 5917 Crosstown Expressway Sh 286, Corpus Christi, TX 78417 Ph: (361) 854-0811 |
News Archive
​Researchers from The University of Manchester and Central Manchester University Hospitals NHS Trust have identified proteins in the blood that could be used to predict whether a woman in her first pregnancy is at increased risk of developing pre-eclampsia.
In 2004, researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center announced a crucial discovery in the understanding of cellular aging. They found that as cells and tissues age, the expression of a key protein, called p16INK4a, dramatically increases in most mammalian organs. Because p16INK4a is a tumor suppressor protein, cancer researchers are interested in its role in cellular aging and cancer prevention.
Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute and Northern Arizona University, and now protected by a patent issued today by the U.S. Patent and Trademark Office.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 9 days ago
Roger Timperlake, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3533 S Alameda St, Corpus Christi, TX 78411 Phone: 361-694-4320 Fax: 361-694-4065 | |
Dr. Aimee Lynn Schimizzi, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6118 Parkway, Corpus Christi, TX 78414 Phone: 361-883-2000 Fax: 361-561-1354 | |
Dr. John Mckeever, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 613 Elizabeth St, Suite 804, Corpus Christi, TX 78404 Phone: 361-881-3351 Fax: 361-861-9022 | |
Dr. Brian L. Patterson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6118 Parkway Dr., Corpus Christi, TX 78414 Phone: 361-883-2000 Fax: 361-561-1354 | |
Dr. Justin John Klimisch, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5917 Crosstown Expressway Sh 286, Corpus Christi, TX 78417 Phone: 361-854-0811 Fax: 361-806-5040 | |
Dr. Matthew David Hnatow, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6118 Parkway Dr, Corpus Christi, TX 78414 Phone: 361-883-2000 | |
Dr. Charles S Clark Jr., M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6118 Parkway Dr., Corpus Christi, TX 78414 Phone: 361-883-2000 Fax: 361-561-1354 |